Advertisement
Advertisement

PYPD

PYPD logo

Polypid Ltd

2.56
USD
+0.055
+2.20%
Dec 18, 11:18 UTC -5
Closed
...

Polypid Ltd Profile

About

PolyPid Ltd. is a pharmaceutical company. It discovers, develops and commercializes antibiotic drugs for the prevention of surgical infections. The company's product candidate includes D-PLEX100, BONYPID-1000 and BONYPID-500 which are in clinical stage. PolyPid Ltd. is based in Petach Tikva, Israel.

Info & Links

CEO

Dikla Czaczkes Akselbrad

Headquarters

18 HASIVIM STREET
PETACH TIKVA, L3 495376, ISRAEL

Industry

Pharmaceuticals Major

Sector

Health Technology

Website

www.polypid.com

Auditor

Kost Forer Gabbay & Kasierer

Share holders

--

Employees

79

Polypid Ltd Statistics

Valuation Measures

Market Capitalization2

12.26M

Enterprise Value

15.00M

Enterprise Value/EBITDA(ttm)

-0.58

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

5.80

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-1219.71%

Return on Invested Capital(ttm)

-503.48%

Return on Assets(ttm)

-134.48%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

--

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-25.81M

Net Income Available to Common(ttm)

-26.86M

Diluted EPS(ttm)

-7.81

Share Statistics

Beta (5Y Monthly)

1.33

52-Week Change

-48.90%

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

--

Dividend Yield

0.00%

Float4

3.61M

% Held by Insiders

24.70%

% Held by Institutions

26.47%

Balance Sheet

Total Cash(mrq)

9.70M

Total Cash Per Share(mrq)

--

Total Debt(mrq)

7.71M

Total Debt/Equity(mrq)

357.14%

Current Ratio(mrq)

1.00%

Quick Ratio(mrq)

1.00%

Book Value Per Share(mrq)

0.32

Cash Flow

Operating Cash Flow Per Share(ytd)

--

Free Cash Flow(ytd)

0.00

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement